home / stock / iccm / iccm news


ICCM News and Press, IceCure Medical Ltd. From 05/22/23

Stock Information

Company Name: IceCure Medical Ltd.
Stock Symbol: ICCM
Market: NASDAQ
Website: icecure-medical.com

Menu

ICCM ICCM Quote ICCM Short ICCM News ICCM Articles ICCM Message Board
Get ICCM Alerts

News, Short Squeeze, Breakout and More Instantly...

ICCM - IceCure Medical Reports First Quarter 2023 Financial & Operational Results

IceCure Medical Reports First Quarter 2023 Financial & Operational Results IceCure Medical Reports First Quarter 2023 Financial & Operational Results PR Newswire Physician Interest and Adoption of ProSense in the U.S. Builds Momentum as ProSense is Featured at ...

ICCM - IceCure to Report First Quarter 2023 Financial & Operational Results on

IceCure to Report First Quarter 2023 Financial & Operational Results on IceCure to Report First Quarter 2023 Financial & Operational Results on PR Newswire CAESAREA, Israel , May 15, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ...

ICCM - Cryoablation Takes Center Stage at American Society of Breast Surgeons' 24th Annual Meeting

Cryoablation Takes Center Stage at American Society of Breast Surgeons' 24th Annual Meeting PR Newswire IceCure's ProSense was the cryoablation system used in first-of-its-kind cryotherapy continuing medical education (CME) course High level of interest express...

ICCM - IceCure Medical to Provide Educational Support in a First-of-its-Kind Cryotherapy Course at the American Society of Breast Surgeons' 24th Annual Meeting

IceCure Medical to Provide Educational Support in a First-of-its-Kind Cryotherapy Course at the American Society of Breast Surgeons' 24th Annual Meeting PR Newswire Physicians Attending the CME Course to Demo ProSense, Learn More About Breast Cryoablation, and Receive Hand...

ICCM - IceCure's ProSense System Used in Endometriosis Cryoablation Study That Demonstrated Efficacy Rate of 92.8% to Avoid Secondary Surgery

IceCure's ProSense System Used in Endometriosis Cryoablation Study That Demonstrated Efficacy Rate of 92.8% to Avoid Secondary Surgery PR Newswire ProSense System among the two types of systems used in the study Pain-free survival rates of 93.75% at 6 months an...

ICCM - IceCure Medical to delist from Tel Aviv Stock Exchange

2023-04-19 08:24:19 ET IceCure Medical ( NASDAQ: ICCM ) said on Wednesday that it has initiated a process to voluntarily delist its shares from the Tel Aviv Stock Exchange. The last day for the shares to trade on TASE will be July 20, and the shares will be delisted from the s...

ICCM - IceCure Medical Ordinary Shares to Trade Exclusively on Nasdaq: Company to Voluntarily Delist Shares from Trading on the Tel Aviv Stock Exchange

IceCure Medical Ordinary Shares to Trade Exclusively on Nasdaq: Company to Voluntarily Delist Shares from Trading on the Tel Aviv Stock Exchange PR Newswire CAESAREA , Israel , April 19, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("...

ICCM - IceCure Medical Ltd (ICCM) Q4 2022 Earnings Call Transcript

2023-03-29 13:33:06 ET IceCure Medical Ltd (ICCM) Q4 2023 Earnings Conference Call March 29, 2023 10:00 a.m. ET Company Participants Eyal Shamir - CEO Ronen Tsimerman - CFO & COO Todd Kehrli - EVC Group, IR Conference Call Participants Kemp Dolliv...

ICCM - IceCure Medical GAAP EPS of -$0.46 misses by $0.35, revenue of $3.1M beats by $2.1M

2023-03-29 08:07:09 ET IceCure Medical press release ( NASDAQ: ICCM ): FY GAAP EPS of -$0.46 misses by $0.35 . Revenue of $3.1M (-24.4% Y/Y) beats by $2.1M . Gross margin was approximately 47% for the twelve months ended December 31, 2022, compared to approxima...

ICCM - IceCure Medical Reports 2022 Full Year Financial Results & Recent Corporate Developments; Milestone Achievements Expected to Drive Revenue Growth in 2023

IceCure Medical Reports 2022 Full Year Financial Results & Recent Corporate Developments; Milestone Achievements Expected to Drive Revenue Growth in 2023 IceCure Medical Reports 2022 Full Year Financial Results & Recent Corporate Developments; Milestone Achievements Expected to ...

Previous 10 Next 10